Healthcare Global Enterprises Rights Issue 2026 Details, Record Date, Issue Price

Healthcare Global Enterprises Rights Issue details are now available. The firm plans to issue 82,94,566 equity shares amounting to Rs 424.68 crores. Healthcare Global Enterprises Rights issue price is Rs 512 per share, and the face value is Rs 10 per share.

Healthcare Global Enterprises Rights Issue open date is March 11, 2026 and the close date is March 25, 2026. Healthcare Global Enterprises rights issue entitlement ratio is 1:17, which is 1 Rights Equity Shares for every 17 fully paid-up Equity Shares held on the record date.

Healthcare Global Enterprises Rights Issue record date is March 2, 2026. The last date to buy shares of Healthcare Global Enterprises is February 27, 2026. This rights Issue subscription status will be available soon.

Healthcare Global Enterprises Rights Issue allotment date is March 27, 2026, credit date March 30, 2026 and the listing date is April 1, 2026. However, the listing will be on the BSE and NSE.

Healthcare Global Enterprises rights issue registrar is Kfin Technologies Ltd and the book-running lead manager(s) for this rights issue will be available soon.

Healthcare Global Enterprises Rights Issue Details

Healthcare Global Enterprises Rights Issue details are as follows: the company plans to issue 82,94,566 equity shares, aggregating the amount of Rs 424.68 crores. Healthcare Global Enterprises Rights issue price is Rs 512 per share. The rights issue entitlement ratio is 1:17, which is 1 Rights Equity Shares for every 17 fully paid-up equity share(s).

Healthcare Global Enterprises Rights Issue Dates

Healthcare Global Enterprises Rights issue record date is March 2, 2026 and the last date to buy shares of Healthcare Global Enterprises is February 27, 2026.

Healthcare Global Enterprises Rights Issue Subscription

Healthcare Global Enterprises Rights Issue subscription status will be available after the issue goes live. The details of the Rights Issue entitlement are 1 Rights Equity Share(s) for every 17 fully paid-up Equity Share(s) held on the Record Date. Healthcare Global Enterprises issue price is Rs 512 per share.

Healthcare Global Enterprises Limited: About the Company

Healthcare Global Enterprises Limited is a leading cancer‑care and multi‑specialty hospital network based in Bengaluru, established in 1989 under the name Bangalore Institute of Oncology before evolving into its current corporate structure. The company designs, builds and manages a pan‑India network of comprehensive cancer centres, multi‑specialty hospitals and day‑care facilities, offering advanced diagnostics, surgical and oncology services across major cities. It focuses on integrated care delivery, combining clinical expertise with research and technology to support complex treatment protocols and improve patient outcomes.

The organization operates as a physician‑led healthcare group with a strong emphasis on clinical governance, research‑driven protocols and continuous improvement in service standards. Its model spans hospital management, clinical laboratories, precision oncology and medical value travel, helping patients’ access specialised care both domestically and from select international markets. Healthcare Global Enterprises Limited continues to expand its footprint and service capabilities, aiming to strengthen accessibility to high‑quality oncology and tertiary‑care services in India’s evolving healthcare landscape.

Healthcare Global Enterprises Limited Financials (Amount in Rs crore)

Healthcare Global Enterprises Rights Issue Registrar

Healthcare Global Enterprises rights issue registrar is Kfin Technologies Ltd. and the book-running lead manager(s) for this rights issue will be available soon.

FAQs

1. What are the details of the Healthcare Global Enterprises Rights Issue?

Healthcare Global Enterprises Rights Issue details are as follows: Healthcare Global Enterprises plans to issue 82,94,566 equity shares amounting to Rs 424.68 crores. Healthcare Global Enterprises Rights issue price is Rs 512 per share, and the face value is Rs 10 per share. The rights issue entitlement ratio is 1:17, which is 1 Rights Equity Share(s) for every 17 fully paid-up equity share(s).

2. Healthcare Global Enterprises Rights Issue open date and close date?

Healthcare Global Enterprises Rights Issue's open date is March 11, 2026, and the closing date is March 25, 2026. Healthcare Global Enterprises Rights Issue record date is March 2, 2026. The last date to buy shares of Healthcare Global Enterprises is February 27, 2026.

3. How can I apply for the Healthcare Global Enterprises Rights Issue?

You can apply for Healthcare Global Enterprises in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Healthcare Global Enterprises Rights Issue?

Healthcare Global Enterprises rights issue entitlement ratio is 1:17, which is 1 Rights Equity Share(s) for every 17 fully paid-up equity share(s).

5. How can I check the Healthcare Global Enterprises Issue Allotment Status?

The registrar for the Healthcare Global Enterprises rights Issue is Kfin Technologies Ltd, Investors can check the allotment status by visiting the registrar's website.

6. From where can I get the Healthcare Global Enterprises Rights Issue Letter of Offer?

You can download the Healthcare Global Enterprises Rights Issue Letter of Offer from here.

7. What is the listing date of the Healthcare Global Enterprises Rights Issue?

The Healthcare Global Enterprises Rights Issue listing date is April 1, 2025. However, the listing will be on the BSE and NSE.

8. Who is the registrar and the lead manager of the Healthcare Global Enterprises Rights Issue?

Healthcare Global Enterprises rights issue registrar is Kfin Technologies Ltd. and the book-running lead manager(s) for this rights issue will be available soon.